264 related articles for article (PubMed ID: 15163283)
1. Rivastigmine in vascular dementia.
Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
Expert Opin Pharmacother; 2004 Jun; 5(6):1399-410. PubMed ID: 15163283
[TBL] [Abstract][Full Text] [Related]
2. Rivastigmine in subcortical vascular dementia: an open 22-month study.
Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
J Neurol Sci; 2002 Nov; 203-204():141-6. PubMed ID: 12417373
[TBL] [Abstract][Full Text] [Related]
3. Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients.
Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
Am J Alzheimers Dis Other Demen; 2003; 18(5):265-72. PubMed ID: 14569643
[TBL] [Abstract][Full Text] [Related]
4. [Effect of AChE and BuChE inhibition by rivastigmin in a group of old-old elderly patients with cerebrovascular impairment (SIVD type)].
Servello A; Andreozzi P; Bechini F; De Angelis R; Pontecorvo ML; Vulcano A; Cerra E; Vigliotta MT; Artini M; Selan L; Ettorre E
Minerva Med; 2014 Apr; 105(2):167-74. PubMed ID: 24727881
[TBL] [Abstract][Full Text] [Related]
5. Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.
Kandiah N; Pai MC; Senanarong V; Looi I; Ampil E; Park KW; Karanam AK; Christopher S
Clin Interv Aging; 2017; 12():697-707. PubMed ID: 28458525
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study.
Moretti R; Torre P; Antonello RM; Cazzato G; Griggio S; Ukmar M; Bava A
Int J Clin Pract; 2004 Apr; 58(4):346-53. PubMed ID: 15161118
[TBL] [Abstract][Full Text] [Related]
7. Rivastigmine in vascular dementia.
Vincent S; Lane R
Int Psychogeriatr; 2003; 15 Suppl 1():201-5. PubMed ID: 16191241
[TBL] [Abstract][Full Text] [Related]
8. The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.
Bullock R
Int J Clin Pract; 2002 Apr; 56(3):206-14. PubMed ID: 12018828
[TBL] [Abstract][Full Text] [Related]
9. Rivastigmine for Alzheimer's disease.
Drug Ther Bull; 2000 Feb; 38(2):15-6. PubMed ID: 10829350
[TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition.
Ballard CG
Eur Neurol; 2002; 47(1):64-70. PubMed ID: 11803198
[TBL] [Abstract][Full Text] [Related]
11. Rivastigmine for subcortical vascular dementia.
Román GC
Expert Rev Neurother; 2005 May; 5(3):309-13. PubMed ID: 15938663
[TBL] [Abstract][Full Text] [Related]
12. Update on rivastigmine.
Farlow MR
Neurologist; 2003 Sep; 9(5):230-4. PubMed ID: 14587496
[TBL] [Abstract][Full Text] [Related]
13. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
Bullock R; Cameron A
Curr Med Res Opin; 2002; 18(5):258-64. PubMed ID: 12240787
[TBL] [Abstract][Full Text] [Related]
14. Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Grace J; Daniel S; Stevens T; Shankar KK; Walker Z; Byrne EJ; Butler S; Wilkinson D; Woolford J; Waite J; McKeith IG
Int Psychogeriatr; 2001 Jun; 13(2):199-205. PubMed ID: 11495394
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil.
Auriacombe S; Pere JJ; Loria-Kanza Y; Vellas B
Curr Med Res Opin; 2002; 18(3):129-38. PubMed ID: 12094822
[TBL] [Abstract][Full Text] [Related]
16. Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
Robert P
Curr Med Res Opin; 2002; 18(3):156-71. PubMed ID: 12094826
[TBL] [Abstract][Full Text] [Related]
17. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease.
Jann MW
Pharmacotherapy; 2000 Jan; 20(1):1-12. PubMed ID: 10641971
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Rösler M
Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
[TBL] [Abstract][Full Text] [Related]
19. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Rombouts SA; Barkhof F; Van Meel CS; Scheltens P
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):665-71. PubMed ID: 12438467
[TBL] [Abstract][Full Text] [Related]
20. Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman.
Alagiakrishnan K; Sclater A; Robertson D
J Am Geriatr Soc; 2003 Sep; 51(9):1326. PubMed ID: 12919253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
